SOLLY ABRAHAM: Open Payments
NPI 1932246436 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 20 payments from 16 companies in 2025. Trend: 2023 $1,207 · 2024 $449 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $142 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $131 |
| Phathom Pharmaceuticals, Inc. | 1 | $110 |
| Grifols USA, LLC | 1 | $103 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Insmed, Inc. | 1 | $98 |
| Dexcom, Inc. | 1 | $67 |
| Saluda Medical Americas, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 1 | $40 |
Products named: WaveWriter Alpha Prime 16, INGREZZA, VOQUEZNA, Prolastin-C Liquid, Arikayce, XIFAXAN, Dexcom G6 Transmitter, Evoke.
Industry payments across MD — which companies pay providers there.
